Hemarina helps to heal injuries in reconstructive surgery with HEMO2life® oxygen carrier
6 May 2022During his visit to France’s Percy Army Training Hospital on 28 April 2022, The French President met several soldiers who... View Article
Oncology: OSE Immunotherapeutics receives 10 million euros from Boehringer Ingelheim
5 May 2022Initiation of the Phase 1 clinical expansion trial triggers a €10 million milestone payment from Boehringer Ingelheim to OSE Immunotherapeutics.... View Article
Defymed and GlioCure initiate a collaboration in the field of solid tumours without therapeutic options
GlioCure, a neuro-oncology drug development company based in Angers, France, and Defymed, a Strasbourg-based medical technology company, have set themselves... View Article